Drug
Squalamine lactate clinical trials
A product of Squalamine; its studies count on that page too.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2004 (2)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 4
Genaera Corporation (4) · Ohr Pharmaceutical Inc. (1) · Elman Retina Group (1) · Jonsson Comprehensive Cancer Center (1) · Starr Muscle (1) · OHSU Knight Cancer Institute (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Squalamine
Studies
Open first, then newest update. How each study uses squalamine lactate is read from its arms, and is right about nine times in ten.
Testing it · 9
- Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)WithdrawnPhase 2Starr MuscleNCT02349516Written as Squalamine Lactate Ophthalmic Solution 0.2%
- Efficacy and Safety of Squalamine Lactate Eye Drops in Subjects With Neovascular (Wet) Age-related Macular Degeneration (AMD)CompletedPhase 2Ohr Pharmaceutical Inc.NCT01678963Written as Squalamine lactate
- Squalamine for the Treatment in Proliferative Diabetic RetinopathyCompletedPhase 2Elman Retina GroupNCT01769183Written as Squalamine Lactate ophthalmic solution 0.2%
- Squalamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian CancerStatus unknownPhase 2Jonsson Comprehensive Cancer CenterNCT00021385Written as squalamine lactate
- Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate CancerWithdrawnPhase 2OHSU Knight Cancer InstituteNCT00244920Written as squalamine lactate
- MSI-1256F (Squalamine Lactate) in Combination With Verteporfin in Patients With "Wet" Age-Related Macular Degeneration (AMD)TerminatedPhase 2Genaera CorporationNCT00094120Written as MSI-1256F (Squalamine Lactate)
- A Safety and Efficacy Study of Squalamine Lactate for Injection (MSI-1256F) for "Wet" Age-Related Macular DegenerationTerminatedPhase 3Genaera CorporationNCT00139282Written as Squalamine Lactate
- A Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationTerminatedPhase 2Genaera CorporationNCT00333476Written as MSI-1256F (Squalamine Lactate)
- A Safety and Efficacy Study of MSI-1256F (Squalamine Lactate) To Treat "Wet" Age-Related Macular DegenerationTerminatedPhase 2Genaera CorporationNCT00089830Written as MSI-1256F (Squalamine Lactate)
Codes
What other systems call squalamine lactate · ClinicalTrials.gg INT004682
- MeSH (NLM) C488568squalamine lactateOne source NLM
- UNII (FDA) 4WE915J1KXSQUALAMINE LACTATEConfirmed FDA, NLM, Wikidata
- Wikidata Q27260597squalamine lactate hydrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1482Squalamine LactateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C488568 | squalamine lactate | One source NLM |
| UNII (FDA) | 4WE915J1KX | SQUALAMINE LACTATE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27260597 | squalamine lactate hydrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1482 | Squalamine Lactate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.